Patents by Inventor Esma Ucisik-Akkaya

Esma Ucisik-Akkaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE NUCLEOTIDE POLYMORPHISMS AND USE OF SAME IN PREDICTING MALE-SPECIFIC PRENATAL LOSS
    Publication number: 20140045710
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Application
    Filed: February 12, 2013
    Publication date: February 13, 2014
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do
  • Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss
    Patent number: 8394587
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: March 12, 2013
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do
  • Single nucleotide polymorphisms as genetic markers for childhood leukemia
    Publication number: 20100092959
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific childhood leukemia risk. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk or a decreased risk for childhood leukemia for males and females is also disclosed.
    Type: Application
    Filed: June 3, 2009
    Publication date: April 15, 2010
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Thuy Ngoc Do, Charronne Davis, Brittany Morrison
  • Single nucleotide polymorphisms and use of same predicting male- specific prenatal loss
    Publication number: 20100081135
    Abstract: The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed.
    Type: Application
    Filed: April 14, 2009
    Publication date: April 1, 2010
    Applicant: Medical Diagnostic Laboratories, LLC
    Inventors: Mehmet Tevfik Dorak, Esma Ucisik-Akkaya, Charronne Davis, Thuy Ngoc Do